Lineage Cell Therapeutics (LCTX) Tax Rate (2014 - 2023)

Lineage Cell Therapeutics' Tax Rate history runs 5 years deep, the most recent figure standing at 29.05% for Q1 2023.

• In Q1 2023, Tax Rate changed N/A year-over-year to 29.05%; the TTM figure through Dec 2023 stood at 7.74% (down 4866.0% YoY), while the FY2025 annual figure was 7.69%, changed N/A from the prior year.
• Tax Rate for Q1 2023 stood at 29.05%, up from 0.64% in the prior quarter.
• The five-year high for Tax Rate was 262.3% in Q4 2019, with the low at 8.97% in Q3 2022.
• The 4-year median for Tax Rate is 6.04% (2021), against an average of 37.18%.
• Peak annual rise in Tax Rate reached 2041 bps in 2022, while the deepest fall reached 2041 bps in 2022.
• Lineage Cell Therapeutics' Tax Rate stood at 262.3% in 2019, then plunged by 96 bps to 11.44% in 2021, then slumped by 94 bps to 0.64% in 2022, then soared by 4407 bps to 29.05% in 2023.
• Business Quant data shows LCTX's Tax Rate at 29.05% in Q1 2023, 0.64% in Q4 2022, and 8.97% in Q3 2022.